PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Tsuri T et al. Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane derivatives: orally active, potent, and selective prostaglandin D2 receptor antagonists. 1997 J. Med. Chem. pmid:9357516
Liakos P et al. ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells. 1997 Am. J. Physiol. pmid:9357777
Minami T et al. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. 1997 Br. J. Pharmacol. pmid:9375954
Li Y et al. Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. 1997 Prostaglandins pmid:9380795
Fournier T et al. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. 1997 J. Biol. Chem. pmid:9388257
Wettstein M and Häussinger D Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. 1997 Hepatology pmid:9397998
Adams M et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. 1997 J. Clin. Invest. pmid:9399962
Ricote M et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. 1998 Nature pmid:9422508
Jiang C et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. 1998 Nature pmid:9422509
McGowan SE et al. Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts. 1997 Am. J. Physiol. pmid:9435581
Reginato MJ et al. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. 1998 J. Biol. Chem. pmid:9442016
Tan W et al. Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons. 1998 J. Neurophysiol. pmid:9463448
Nagoshi H et al. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. 1998 Circ. Res. pmid:9468191
Horak F et al. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. 1998 Allergy pmid:9491231
el Attar TM and Virji AS Effects of indomethacin, cisplatin and delta 12-prostaglandin J2 on growth of oral squamous carcinoma cells. 1997 Nov-Dec Anticancer Res. pmid:9494540
Urade Y [New aspects on prostaglandin D synthases]. 1997 Nippon Yakurigaku Zasshi pmid:9503406
Hayaishi O [Prostaglandins and sleep]. 1998 Nippon Rinsho pmid:9503823
Urade Y [Gene engineering studies on sleep]. 1998 Nippon Rinsho pmid:9503856
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Giardiello FM et al. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. 1998 Dig. Dis. Sci. pmid:9512123
Ward PE et al. Niacin skin flush in schizophrenia: a preliminary report. 1998 Schizophr. Res. pmid:9516668
Mezei Z et al. Platelet eicosanoids and the effect of captopril in blood pressure regulation. 1997 Eur. J. Pharmacol. pmid:9527508
Rossi AG et al. Regulation of macrophage phagocytosis of apoptotic cells by cAMP. 1998 J. Immunol. pmid:9531319
Boie Y et al. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. 1997 Eur. J. Pharmacol. pmid:9537820
Liao CH et al. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets. 1998 Jpn. J. Pharmacol. pmid:9541276
Austin S et al. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. 1998 Cell Growth Differ. pmid:9543393
Fukushima S et al. [Pharmaceutical and pharmacological development of antitumor prostaglandins]. 1998 Nippon Rinsho pmid:9549353
Akarsu ES et al. Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2. 1998 Epilepsy Res. pmid:9551845
Daculsi R et al. Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes. 1998 Immunol. Lett. pmid:9557948
Chan CL and Lau HY Effects of prostanoid receptor agonists on immunologically-activated rat peritoneal mast cells. 1998 Inflamm. Res. pmid:9561397
Lau HY and Stenton GR Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells. 1998 Inflamm. Res. pmid:9561398
Yang VW et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. 1998 Cancer Res. pmid:9563494
Mooney JJ et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). 1998 Biol. Psychiatry pmid:9564442
Souza SC et al. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. 1998 Diabetes pmid:9568706
Nagy L et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. 1998 Cell pmid:9568715
Tontonoz P et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. 1998 Cell pmid:9568716
Morrow JD et al. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. 1998 Arch. Biochem. Biophys. pmid:9578611
Wright DH et al. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. 1998 Br. J. Pharmacol. pmid:9579725
Dorta-Contreras AJ et al. [Beta trace protein in the cerebrospinal fluid and serum in meningoencephalitis]. 1998 Rev Neurol pmid:9585948
Kalgutkar AS et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 1998 Science pmid:9596581
Tsai WJ et al. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina. 1998 Eur. J. Pharmacol. pmid:9617759
Demoly P et al. [Nose and sinus: anatomo-pathologic relations]. 1998 Allerg Immunol (Paris) pmid:9631692
Scammell T et al. Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9636223
Moon TC et al. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. 1998 Cell. Immunol. pmid:9636692
Iijima K et al. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells. 1998 Biochem. Biophys. Res. Commun. pmid:9642130
Ikai K et al. Induction of apoptosis, p53 and heme oxygenase-1 by cytotoxic prostaglandin delta12-PGJ2 in transformed endothelial cells. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9654403
Nishino S et al. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. 1998 Psychiatry Res pmid:9657418
Thomson AM et al. Sequence, catalytic properties and expression of chicken glutathione-dependent prostaglandin D2 synthase, a novel class Sigma glutathione S-transferase. 1998 Biochem. J. pmid:9657971
Marx N et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. 1998 Am. J. Pathol. pmid:9665460
Seckl J Mechanisms of fetal origins of health problems in adults need to be investigated. 1998 BMJ pmid:9665923